论文部分内容阅读
目的探讨重症肺炎与非重症肺炎患者住院医疗费用的差异,合理制定疾病诊断相关分类系统(DRGs)提供依据。方法将25例重症肺炎患者住院医疗费用与247例非重症肺炎患者作对照比较。结果重症肺炎患者住院费用的中位数为3941.62元,非重症肺炎患者为2860.07元(u=2.433,P=0.015),差别显著。重症肺炎患者与非重症肺炎患者药品费用以及诊疗费用的中位数差异均显著(P<0.05)。其他项目医疗费用的差别无统计学意义(P>0.05)。结论抗感染治疗是肺炎治疗的最主要环节,选择广谱的强力抗菌药物,足量、联合用药是重症肺炎的治疗原则之一,故与非重症肺炎患者的住院医疗费用存在明显差别。在制定疾病诊断相关分类系统(DRGs)时,应根据肺炎病例分型的不同特点,分别制定相应标准。
Objective To explore the difference of hospitalization expenses between patients with severe pneumonia and non-severe pneumonia and to provide basis for the rational development of disease-related classification system (DRGs). Methods Twenty-five patients with severe pneumonia were compared with 247 non-severe pneumonia patients. Results The median hospitalization cost was 3941.62 yuan in patients with severe pneumonia and 2860.07 yuan in patients with non-severe pneumonia (u = 2.433, P = 0.015). The difference was significant. The median cost of medication and the cost of treatment for patients with severe pneumonia and non-severe pneumonia were significantly different (P <0.05). Other items of medical expenses difference was not statistically significant (P> 0.05). Conclusion Anti-infective therapy is the most important part of pneumonia treatment. Choosing a broad spectrum of strong antibacterial drugs, adequate dosage and combination therapy are one of the treatment principles of severe pneumonia. Therefore, there is a significant difference in the cost of hospitalization for non-severe pneumonia patients. In the development of disease diagnosis related classification system (DRGs), should be based on the different characteristics of pneumonia case classification, respectively, to develop the corresponding standards.